Literature DB >> 18760473

Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.

Alistair G Reid1, Valeria A De Melo, Kay Elderfield, Ian Clark, David Marin, Jane Apperley, Kikkeri N Naresh.   

Abstract

We identified different phenotypic subsets among 62 cases of chronic myeloid leukemia (CML) in blast crisis (BC) (26% B-lymphoblastic, and 74% various myeloblastic subsets) on bone marrow trephines and correlated the blast-phenotype with cytogenetics. Five of myeloid-BC had an associated 3q26 abnormality and two of these showed a megakaryoblastic-phenotype. While myeloid-BC was associated with additional copies of Philadelphia (Ph) (29%) (p=0.08), numerical abnormalities (51%) (p=0.007), trisomy-8 (29%) (p=0.08) and 17p-loss (22%), none of lymphoid-BC showed these abnormalities. Among myeloid-BC, CD34-negative cases were more often associated with trisomy-8, 17p-loss and numerical abnormalities, and the CD117-negative subset with additional copies of Ph (p<0.05).

Entities:  

Mesh:

Year:  2008        PMID: 18760473     DOI: 10.1016/j.leukres.2008.07.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  A multicellular basis for the origination of blast crisis in chronic myeloid leukemia.

Authors:  Rainer K Sachs; Kerstin Johnsson; Philip Hahnfeldt; Janet Luo; Allen Chen; Lynn Hlatky
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

Review 2.  Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Authors:  Axel Schulenburg; Katharina Blatt; Sabine Cerny-Reiterer; Irina Sadovnik; Harald Herrmann; Brigitte Marian; Thomas W Grunt; Christoph C Zielinski; Peter Valent
Journal:  J Hematol Oncol       Date:  2015-02-25       Impact factor: 17.388

Review 3.  Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.

Authors:  Xiaoning Gao; Jie Li; Lili Wang; Ji Lin; Hongshi Jin; Yihan Xu; Nan Wang; Yu Zhao; Daihong Liu; Li Yu; Quanshun Wang
Journal:  Am J Case Rep       Date:  2016-10-27

Review 4.  Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.

Authors:  Luana Bavaro; Margherita Martelli; Michele Cavo; Simona Soverini
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

5.  Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia.

Authors:  Jie Xu; Shaoying Li
Journal:  Case Rep Hematol       Date:  2014-06-24

Review 6.  Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.

Authors:  Lukasz Komorowski; Klaudyna Fidyt; Elżbieta Patkowska; Malgorzata Firczuk
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

Review 7.  NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Authors:  Gianfranco Catalano; Pasquale Niscola; Cristina Banella; Daniela Diverio; Malgorzata Monika Trawinska; Stefano Fratoni; Rita Iazzoni; Paolo De Fabritiis; Elisabetta Abruzzese; Nelida Ines Noguera
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

8.  An unusual case of T-cell acute lymphoblastic leukemia in a patient with BCR-ABL positive chronic myeloid leukemia and Gaucher disease.

Authors:  Hamdi Al-Janazreh; Yousef S Abuzneid; Iman Khamayseh; Fortunato Morabito; Bilal Alqam; Rosaline M F Abusabbah; Fatima K Mustafa; Shifa Sarahneh
Journal:  Ann Med Surg (Lond)       Date:  2021-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.